Aneurysm Devices In The Regulatory Spotlight: US FDA Panel Meeting Set For March

The agency scheduled a Neurological Devices Panel meeting for March 1 to consider appropriate clinical design and data expectations for intracranial aneurysm devices.

More from Approvals

More from Policy & Regulation